Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
about
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalType 2 diabetes and cognitive impairment: contributions from neuroimagingLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentInsulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's diseaseRole of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseDepression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study.The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.AMPK activation--protean potential for boosting healthspan.Metformin in the diabetic brain: friend or foe?Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort studyTime trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based studyEffects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.Dietary quality may enhance survival related to cognitive impairment in Taiwanese elderlyRisk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study.Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia.Pathways to new drug discovery in neuropsychiatry.A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effectType 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.Increased risk of cognitive impairment in patients with diabetes is associated with metformin.Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila.Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Differential effects of metformin on age related comorbidities in older men with type 2 diabetes.Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI StudyAssociation between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study.Periodontal inflammatory disease is associated with the risk of Parkinson's disease: a population-based retrospective matched-cohort study.Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.Metformin and ageing: improving ageing outcomes beyond glycaemic control.Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use.Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients.Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1.The Therapeutic Potential of Metformin in Neurodegenerative DiseasesMetformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
P2860
Q26783344-BACB593A-354C-4026-8AEC-51E778680DF5Q26825253-CCF77A8C-8C39-4466-89FE-634F2EDA02AFQ26860246-78F28B87-10DD-43CA-8200-E489A65B6E98Q26866392-836D7D42-C7CB-4110-BD81-A390A983040EQ28083039-BA922658-475F-4178-AE3B-AB4980235BE4Q30958558-9B652454-9F0E-4EB0-A2A2-24FE244B880DQ30989565-C948A430-0C68-4937-BE6D-6273CE317E52Q33607272-52C26CA4-ACA4-43D6-80A5-544E436590C0Q33607787-02D577BF-65C4-4207-B521-000AF52AA6F3Q33689169-9FD606BB-B231-41F5-BD2C-97CB2D053C44Q34357977-B4C8F1AE-8DFE-4C7B-BD79-CEDDFB2A6523Q34495632-A2E503E0-FE23-4D40-8899-09D8E38FB6A6Q34660660-20AEA16D-784B-48C9-A97C-85121E6107D8Q35092836-B66A3446-C078-4DE6-9343-6A7F81479E95Q35496857-AA8992BB-61AA-4ABF-B362-DE2461B3CDD5Q35600588-6D29FA7A-A775-454B-B6F8-C8B51134F6BCQ36209650-AB9E7452-CB8D-4A16-A3A0-5C1D51318A7EQ36379186-FEEB79A8-4F7A-4356-AE43-5CA3CA13DBCAQ36490441-325D0D0E-18A2-43D1-A681-57BD9AAAF355Q36594394-CF0F68F3-F44E-415F-B039-D1E873137488Q37070656-B4204608-B27C-4E15-A170-0242F18E3EB6Q37158071-FCE2DD5C-A4D9-435B-A533-95B3A99D34F3Q37193677-5A6754D4-1553-4E6C-A391-55BA3D0B7860Q37262728-0B3607A0-0827-40F6-9B14-CEF9527133DFQ37364862-B997215C-5A9A-450B-BCF7-E044C4396BA4Q37619208-E9E11EA1-0741-443C-B480-BF30C7D44F83Q38234927-9E3368E9-7811-4198-80DE-CE25A432CCC3Q40338946-FE56C1D3-7D32-49DF-9C08-23133B0D46BEQ40638812-FAD7EE3E-D0A8-4FD5-A300-4E286C09391DQ41291483-29B4ADDB-73EB-4248-A216-88B6BD3FD460Q41371529-0D2BC367-8647-462D-B439-8600C5EC284FQ45326103-F084BB70-3849-436C-BDBB-B85321BC3EADQ50431116-D4D5277A-07DE-4E20-96E9-450A7BE01815Q50438218-459BA26F-157B-41DF-B0D2-7A6B77A1B2CEQ52604824-A43720AA-FC4A-4A36-930E-5CDFA2E79101Q55214530-1C9DC2D3-A4F4-4745-B20C-B1CEB61A00DFQ55494305-3EA0CF78-F7E4-4D41-B90D-B6745104D010Q57175337-8DC1F1CA-505F-42A6-A614-15A288711D7CQ58696775-FE170FAB-E646-4BAF-A5B2-362A50BCA29D
P2860
Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@en
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@nl
type
label
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@en
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@nl
prefLabel
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@en
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@nl
P2093
P356
P1476
Incidence of dementia is incre ...... f sulfonylureas and metformin.
@en
P2093
Chih-Cheng Hsu
Hsin-Ni Tsai
Mark L Wahlqvist
Meei-Shyuan Lee
P304
P356
10.3233/JAD-2011-101524
P577
2011-01-01T00:00:00Z